InvestorsHub Logo
icon url

WhiteSahara

02/28/06 12:18 PM

#1966 RE: in2lite #1960

In2lite, thanks for the insight. I have had a difficult time getting information on approval from the company and their PR person. This is really a unique product. I have also emailed the FDA with a description and queried them as to the length of time approval would take. No answer there either.
Best of luck to all of us.

Airdale

icon url

bioscience

02/28/06 2:55 PM

#1970 RE: in2lite #1960

Company Information

Covance Inc Website Annual Report
210 Carnegie Center Phone: +1 609 452-4440
Princeton NEW JERSEY 08540-6233

Fax: +1 609 452-9375


Covance Inc.. The Group's principal activity is to provide a wide range of product development services, on a worldwide basis, primarily to the pharmaceutical, biotechnology and medical device industries. The Group also provides laboratory-testing services to the chemical, agrochemical and food industries. The operations of the Group are carried out through two segments. The Early Development services segment includes preclinical and Phase I clinical service capabilities. This involves evaluating a new compound for safety and early effectiveness as well as evaluating the absorption, distribution, metabolism and excretion of the compound in the human body. The Late-stage Development services segment includes central laboratory, clinical development, commercialization and other clinical support services.

-------

CVD is their ticker.

CoVance spells {Victory} for all CTUM shareholders